Dr. Asad Fraser
Claim this profileGraves Gilbert Clinic
Studies Arthritis
Studies Rheumatoid Arthritis
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Asad Fraser is currently running
Secukinumab
for Giant Cell Arteritis and Polymyalgia Rheumatica
This study will examine how intravenous (i.v.) Secukinumab will be processed in the body (pharmacokinetics \[PK\]) and whether it will be safe and tolerable after multiple doses of i.v. Secukinumab infusion in adult patients with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR).
Recruiting1 award Phase 1
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
More about Asad Fraser
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Asad Fraser has experience with
- Baricitinib
- TNF Inhibitor
- Olokizumab
- Otilimab (GSK3196165)
- GSK3196165 (Otilimab)
- Tofacitinib
Breakdown of trials Asad Fraser has run
Arthritis
- Baricitinib for Rheumatoid Arthritis
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Rheumatoid Arthritis
- Baricitinib for Rheumatoid Arthritis
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Polymyalgia Rheumatica
Giant Cell Arteritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Asad Fraser specialize in?
Asad Fraser focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Asad Fraser currently recruiting for clinical trials?
Yes, Asad Fraser is currently recruiting for 2 clinical trials in Bowling Green Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Asad Fraser has studied deeply?
Yes, Asad Fraser has studied treatments such as Baricitinib, TNF Inhibitor, Olokizumab.
What is the best way to schedule an appointment with Asad Fraser?
Apply for one of the trials that Asad Fraser is conducting.
What is the office address of Asad Fraser?
The office of Asad Fraser is located at: Graves Gilbert Clinic, Bowling Green, Kentucky 42101 United States. This is the address for their practice at the Graves Gilbert Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.